Works matching IS 13596535 AND DT 2024 AND VI 29 AND IP 2

Assessment of swallowability and acceptability of scored darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose combination (FDC) tablets in HIV-1–infected children aged ≥6 to <12 years, using matching placebo tablets: A randomized study

Published in:

Antiviral Therapy, 2024, v. 29, n. 2, p. 1, doi. 10.1177/13596535241248282

By:

• Van Hemelryck, Sandy;
• Van Landuyt, Erika;
• Hufkens, Veerle;
• Vanveggel, Simon

Publication type:

Article